Track topics on Twitter Track topics that are important to you
OTTAWA, July 27, 2015 (GLOBE NEWSWIRE) -- Mitel® (Nasdaq:MITL) (TSX:MNW) a global leader in business communications, today announced that it will release its second quarter 2015 financial results before the market opens on Thursday, August 6, 2015.
The company will host an investor conference call and live webcast at 8:30 a.m. ET (5:30 a.m. PT) on the same day. To access the conference call, dial 888-734-0328. Callers outside the US and Canada should dial 678-894-3054. The conference ID is 85780419. A webcast will be accessible on Mitel's investor relations website at http://investor.mitel.com/.
A replay of the conference call will be available through 5:00 p.m. ET on Monday, August 10, 2015. To access the replay, all callers should please dial 404-537-3406 and enter pass code 85780419.
A global market leader in enterprise and mobile communications powering more than 2 billion business connections and 2 billion mobile subscribers every day, Mitel (Nasdaq:MITL) (TSX:MNW) helps businesses and mobile carriers connect, collaborate and provide innovative services to their customers. Our innovation and communications experts serve more than 60 million business users in more than 100 countries, and 130 mobile service providers including 15 of the top 20 mobile carriers in the world. That makes us unique, and the only company able to provide a bridge between enterprise and mobile customers. For more information, go to www.mitel.com and follow us on Twitter @Mitel.
Mitel is the registered trademark of Mitel Networks Corporation.
All other trademarks are the property of their respective owners.
CONTACT: Media - Americas Amy MacLeod 613-691-3317 email@example.com Media - EMEA/AP Duncan Miller +44 (0) 1291 612 646 firstname.lastname@example.org Investor Michael McCarthy 469-574-8134, email@example.com Industry Analyst Cynthia Navarro 469-574-8113 firstname.lastname@example.orgNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...